Kaneko S - Search Results

1

A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.

Yasui N, Otani K, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Chiba K, Ishizaki T. Yasui N, et al. Among authors: kaneko s. Clin Pharmacol Ther. 1996 May;59(5):514-9. doi: 10.1016/S0009-9236(96)90179-4. Clin Pharmacol Ther. 1996. PMID: 8646822 Clinical Trial.

2

Inhibition of trazodone metabolism by thioridazine in humans.

Yasui N, Otani K, Kaneko S, Ohkubo T, Osanai T, Ishida M, Mihara K, Kondo T, Sugawara K, Fukushima Y. Yasui N, et al. Among authors: kaneko s. Ther Drug Monit. 1995 Aug;17(4):333-5. doi: 10.1097/00007691-199508000-00003. Ther Drug Monit. 1995. PMID: 7482685

3

Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.

Otani K, Yasui N, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Hayashi K, Chiba K, Ishizaki T. Otani K, et al. Among authors: kaneko s. Neuropsychopharmacology. 1997 Jan;16(1):8-14. doi: 10.1016/S0893-133X(96)00165-0. Neuropsychopharmacology. 1997. PMID: 8981384 Clinical Trial.

4

Interaction between carbamazepine and bromperidol.

Otani K, Ishida M, Yasui N, Kondo T, Mihara K, Suzuki A, Furukori H, Kaneko S, Inoue Y. Otani K, et al. Among authors: kaneko s. Eur J Clin Pharmacol. 1997;52(3):219-22. doi: 10.1007/s002280050277. Eur J Clin Pharmacol. 1997. PMID: 9218929

5

Relationship between single oral dose pharmacokinetics of alprazolam and triazolam.

Otani K, Yasui N, Furukori H, Kaneko S, Tasaki H, Ohkubo T, Nagasaki T, Sugawara K, Hayashi K. Otani K, et al. Among authors: kaneko s. Int Clin Psychopharmacol. 1997 May;12(3):153-7. doi: 10.1097/00004850-199705000-00006. Int Clin Psychopharmacol. 1997. PMID: 9248872 Clinical Trial.

6

Single-dose pharmacokinetics and pharmacodynamics of oral triazolam in relation to cytochrome P4502C19 (CYP2C19) activity.

Yasui N, Otani K, Ohkubo T, Osanai T, Sugawara K, Chiba K, Ishizaki T, Kaneko S. Yasui N, et al. Among authors: kaneko s. Ther Drug Monit. 1997 Aug;19(4):371-4. doi: 10.1097/00007691-199708000-00001. Ther Drug Monit. 1997. PMID: 9263374

7

Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype.

Tanaka M, Ohkubo T, Otani K, Suzuki A, Kaneko S, Sugawara K, Ryokawa Y, Hakusui H, Yamamori S, Ishizaki T. Tanaka M, et al. Among authors: kaneko s. Clin Pharmacol Ther. 1997 Dec;62(6):619-28. doi: 10.1016/S0009-9236(97)90081-3. Clin Pharmacol Ther. 1997. PMID: 9433390

8

Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients.

Otani K, Tybring G, Mihara K, Yasui N, Kaneko S, Ohkubo T, Nagasaki T, Sugawara K. Otani K, et al. Among authors: kaneko s. Eur J Clin Pharmacol. 1998 Jan;53(5):347-9. doi: 10.1007/s002280050391. Eur J Clin Pharmacol. 1998. PMID: 9516035

9

Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam.

Furukori H, Otani K, Yasui N, Kondo T, Kaneko S, Shimoyama R, Ohkubo T, Nagasaki T, Sugawara K. Furukori H, et al. Among authors: kaneko s. Neuropsychopharmacology. 1998 May;18(5):364-9. doi: 10.1016/S0893-133X(97)00166-8. Neuropsychopharmacology. 1998. PMID: 9536449 Clinical Trial.

10

Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam.

Yasui N, Kondo T, Otani K, Furukori H, Kaneko S, Ohkubo T, Nagasaki T, Sugawara K. Yasui N, et al. Among authors: kaneko s. Psychopharmacology (Berl). 1998 Oct;139(3):269-73. doi: 10.1007/s002130050715. Psychopharmacology (Berl). 1998. PMID: 9784084 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,525 results

Search Page